林业发展局发布了AI药物开发准则,其中一种AI设计的药物现在正在临床试验中。 The FDA released AI drug development guidelines, with one AI-designed drug now in clinical trials.

林业发展局发布了关于利用人工智能开发药物的新准则,目的是确保AI驱动的药物发现和检测的安全、功效和透明度。 The FDA has released new guidelines for the development of drugs using artificial intelligence, aiming to ensure safety, efficacy, and transparency in AI-driven drug discovery and testing. 该框架概述了在整个药物开发过程中使用的AI系统对数据质量、模型验证和问责制的期望。 The framework outlines expectations for data quality, model validation, and accountability in AI systems used throughout the drug development process. 一种AI型药物已经进入临床试验,标志着在将AI型药物纳入制药创新方面迈出了重要一步。 One AI-designed drug has already entered clinical trials, marking a significant step in integrating AI into pharmaceutical innovation.